Several studies have suggested that mitochondrial metabolism disturbances a
nd mitochondrial DNA (mtDNA) abnormalities may contribute to the progressio
n of the pathology of Alzheimer's disease (AD). In this study we have inves
tigated whether the amount of mtDNA is modified in different brain regions
(cerebellum, hippocampus and frontal cortex) of confirmed AD necropsies and
in blood of living AD patients. We used a real-time PCR method to analyse
the mtDNA relative abundance in brain regions from 12 AD and seven controls
and from a group of blood samples (17 living AD patients and 11 controls).
MtDNA from blood samples together with hippocampus and cerebellum brain ar
eas did not show differences between controls and AD. However, AD patients
showed a 28% decrease in the amount of mtDNA in the frontal cortex when com
pared to controls for this specific area. Since frontal cortex is a severel
y affected region in AD, our results support the hypothesis that mitochondr
ial defects may play a role in the pathogenesis of AD.